Long-term effects of the novel thrombopoietic agent AMG-531 in patients with immune thrombocytopenic purpura
Publication
, Journal Article
Reddy, GK; Shivakumar, L; Muneer, S; Crawford, J
Published in: Supportive Cancer Therapy
January 1, 2007
Duke Scholars
Published In
Supportive Cancer Therapy
DOI
ISSN
1543-2912
Publication Date
January 1, 2007
Volume
4
Issue
2
Start / End Page
72 / 73
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Reddy, G. K., Shivakumar, L., Muneer, S., & Crawford, J. (2007). Long-term effects of the novel thrombopoietic agent AMG-531 in patients with immune thrombocytopenic purpura. Supportive Cancer Therapy, 4(2), 72–73. https://doi.org/10.1016/s1543-2912(13)60023-5
Reddy, G. K., L. Shivakumar, S. Muneer, and J. Crawford. “Long-term effects of the novel thrombopoietic agent AMG-531 in patients with immune thrombocytopenic purpura.” Supportive Cancer Therapy 4, no. 2 (January 1, 2007): 72–73. https://doi.org/10.1016/s1543-2912(13)60023-5.
Reddy GK, Shivakumar L, Muneer S, Crawford J. Long-term effects of the novel thrombopoietic agent AMG-531 in patients with immune thrombocytopenic purpura. Supportive Cancer Therapy. 2007 Jan 1;4(2):72–3.
Reddy, G. K., et al. “Long-term effects of the novel thrombopoietic agent AMG-531 in patients with immune thrombocytopenic purpura.” Supportive Cancer Therapy, vol. 4, no. 2, Jan. 2007, pp. 72–73. Scopus, doi:10.1016/s1543-2912(13)60023-5.
Reddy GK, Shivakumar L, Muneer S, Crawford J. Long-term effects of the novel thrombopoietic agent AMG-531 in patients with immune thrombocytopenic purpura. Supportive Cancer Therapy. 2007 Jan 1;4(2):72–73.
Published In
Supportive Cancer Therapy
DOI
ISSN
1543-2912
Publication Date
January 1, 2007
Volume
4
Issue
2
Start / End Page
72 / 73
Related Subject Headings
- Oncology & Carcinogenesis